Data as of Jan 26
| +5.90 / +2.11%|
The 19 analysts offering 12-month price forecasts for Actavis have a median target of 310.00, with a high estimate of 350.00 and a low estimate of 268.00. The median estimate represents a +8.76% increase from the last price of 285.02.
The current consensus among 25 polled investment analysts is to Buy stock in Actavis. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.